| 词条 | Aminoestradiol |
| 释义 |
| Verifiedfields = | Watchedfields = | verifiedrevid = | IUPAC_name = (8R,9S,13S,14S,17S)-17-Amino-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-ol | image = 17β-Aminoestradiol.svg | width = 250 | tradename = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion = | CAS_number_Ref = | CAS_number = | CAS_supplemental = | ATC_prefix = | ATC_suffix = | ATC_supplemental = | PubChem = 11231075 | IUPHAR_ligand = | DrugBank_Ref = | DrugBank = | ChemSpiderID_Ref = | ChemSpiderID = 9406123 | UNII = | KEGG = | ChEBI = | ChEMBL = | C= 18| H= 25| N= 1| O= 1 | SMILES = C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2N)CCC4=C3C=CC(=C4)O | StdInChI_Ref = | StdInChI = 1S/C18H25NO/c1-18-9-8-14-13-5-3-12(20)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-17,20H,2,4,6-9,19H2,1H3/t14-,15-,16+,17+,18+/m1/s1 | StdInChIKey_Ref = | StdInChIKey = VPONVJPFULJPAN-ZBRFXRBCSA-N | synonyms = AE2; 17βAE2; 17β-Aminoestra-1,3,5(10)-trien-3-ol; 3-Hydroxy-17β-aminoestra-1,3,5(10)-triene }}Aminoestradiol (AE2), also known as 17β-aminoestradiol (17βAE2) or as 17β-aminoestra-1,3,5(10)-trien-3-ol, is a synthetic, steroidal estrogen and a 17β-aminoestrogen with anticoagulant effects that was never marketed.[1][2][3][4][5] It is an analogue of estradiol in which the C17β hydroxyl group has been replaced with an amine group.[1][2] AE2 has profoundly reduced estrogenic potency compared to estradiol; its EC50 for activation of the ERα was found to be 1.82 μM, whereas that of estradiol was 2.14 nM (relative potency 0.12 for AE2 versus 100 for estradiol, or roughly a 1,000-fold difference).[2] It binds with low relative affinity to both the ERα and ERβ and has estrogenic activity that is greatly mediated through the ERβ and to a lesser extent through the ERα.[2] References1. ^1 {{cite journal | vauthors = Lemini C, Rubio-Póo C, Franco Y, Jaimez R, Avila ME, Medina M, Lemus AE | title = In vivo profile of the anticoagulant effect of 17ß-amino-1,3,5(10)estratrien-3-ol | journal = Eur. J. Pharmacol. | volume = 700 | issue = 1-3 | pages = 210–6 | year = 2013 | pmid = 23305838 | doi = 10.1016/j.ejphar.2012.12.030 | url = }} {{Estrogen receptor modulators}}{{steroid-stub}}{{genito-urinary-drug-stub}}2. ^1 2 3 {{cite journal | vauthors = Lemini C, Jaimez R, Pozas R, Franco Y, Avila ME, Figueroa A, Medina M, Lemus AE, García-Becerra R, Ordaz-Rosado D, Larrea F | title = In vivo and in vitro estrogenic profile of 17β-amino-1,3,5(10)estratrien-3-ol | journal = J. Steroid Biochem. Mol. Biol. | volume = 147 | issue = | pages = 40–7 | year = 2015 | pmid = 25448750 | doi = 10.1016/j.jsbmb.2014.11.019 | url = }} 3. ^{{cite journal | vauthors = Ye YH, Huang YS, Wang ZQ, Chen SM, Tian Y | title = Synthesis of new amino acid and peptide derivatives of estradiol and their binding affinities for the estrogen receptor | journal = Steroids | volume = 58 | issue = 1 | pages = 35–9 | year = 1993 | pmid = 8430443 | doi = | url = }} 4. ^{{cite journal | vauthors = Li Z, Yan M, Li Z, Vuki M, Wu D, Liu F, Zhong W, Zhang L, Xu D | title = A multiplexed screening method for agonists and antagonists of the estrogen receptor protein | journal = Anal Bioanal Chem | volume = 403 | issue = 5 | pages = 1373–84 | year = 2012 | pmid = 22453607 | doi = 10.1007/s00216-012-5933-7 | url = }} 5. ^{{cite journal | vauthors = Lemini C, Cruz-Ramos E, Toscano RA, Cruz-Almanza R | title = A comparative structural study of the steroid epimers: 17 beta-amino-1,3,5(10)-estratrien-3-ol, 17 alpha-amino-1,3,5(10)-estratrien-3-ol, and some derivatives by 1H NMR, and x-ray diffraction analysis | journal = Steroids | volume = 63 | issue = 11 | pages = 556–64 | year = 1998 | pmid = 9830681 | doi = | url = }} 5 : Alcohols|Amines|Anticoagulants|Estranes|Synthetic estrogens |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。